Perceived risk, illness perception and dispositional optimism related to COVID-19 among oncologic outpatients undergoing in-hospital treatments and healthy controls.

Autor: Gabanelli P; Istituti Clinici Scientifici Maugeri IRCCS, Psychology Unit of Pavia Institute, Italy., Monzani D; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Applied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, Italy., Fiabane E; Department of Physical and Rehabilitation Medicine of Nervi Institute, Istituti Clinici Scientifici Maugeri IRCCS, Italy., Quaquarini E; Istituti Clinici Scientifici Maugeri IRCCS, Operative Unit of Medical Oncology of Pavia Institute, Italy., Frascaroli M; Istituti Clinici Scientifici Maugeri IRCCS, Operative Unit of Translational Oncology of Pavia Institute, Italy., Balletti E; Istituti Clinici Scientifici Maugeri IRCCS, Operative Unit of Medical Oncology of Pavia Institute, Italy., Bernardo A; Istituti Clinici Scientifici Maugeri IRCCS, Operative Unit of Medical Oncology of Pavia Institute, Italy., Teragni CM; Istituti Clinici Scientifici Maugeri IRCCS, Operative Unit of Medical Oncology of Pavia Institute, Italy., Grossi F; Istituti Clinici Scientifici Maugeri IRCCS, Psychology Unit of Pavia Institute, Italy., Pravettoni G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Applied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, Italy., Gorini A; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Istituti Clinici Scientifici Maugeri IRCCS, Milano Institute, Italy.

Publikováno v: Psychology & health [Psychol Health] 2024 Mar-Apr; Vol. 39 (3), pp. 417-433. Date of Electronic Publication: 2022 Apr 17.

Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study.

Autor: Quaquarini E; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy., Sottotetti F; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy., Agustoni F; Medical Oncology Unit, IRCCS San Matteo Hospital Foundation, 27100 Pavia, Italy., Pozzi E; Oncology Unit, Ospedale Civile, 27058 Voghera, Italy., Malovini A; Laboratory of Informatics and System Engineering for Clinical Research, ICS Maugeri-IRCCS SpA SB, Via Maugeri 10, 27100 Pavia, Italy., Teragni CM; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy., Palumbo R; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy., Saltalamacchia G; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy.; Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy., Tagliaferri B; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy., Balletti E; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy., Rinaldi P; Unit of Thoracic Surgery, IRCCS San Matteo Hospital Foundation, 27100 Pavia, Italy., Canino C; Medical Oncology Unit, IRCCS San Matteo Hospital Foundation, 27100 Pavia, Italy.; Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy., Pedrazzoli P; Medical Oncology Unit, IRCCS San Matteo Hospital Foundation, 27100 Pavia, Italy.; Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy., Bernardo A; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy.

Publikováno v: Journal of personalized medicine [J Pers Med] 2022 Apr 24; Vol. 12 (5). Date of Electronic Publication: 2022 Apr 24.

Role of androgen receptor expression in early stage ER+/PgR-/HER2- breast cancer.

Autor: Tagliaferri B; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy., Quaquarini E; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, via Maugeri 10, Pavia, 27100, Italy., Palumbo R; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy., Balletti E; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy., Presti D; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy., Malovini A; Laboratory of Informatics and System Engineering for Clinical Research, ICS Maugeri-IRCCS SpA SB, Pavia, Italy., Agozzino M; Operative Unit of Anatomic Pathology, ICS Maugeri-IRCCS SpA SB, Pavia, Italy., Teragni CM; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy., Terzoni A; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy., Bernardo A; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy., Villani L; Operative Unit of Anatomic Pathology, ICS Maugeri-IRCCS SpA SB, Pavia, Italy., Sottotetti F; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy.

Publikováno v: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2020 Sep 17; Vol. 12, pp. 1758835920958355. Date of Electronic Publication: 2020 Sep 17 (Print Publication: 2020).